Relative Toxicity of Cardiotonic Agents: Some Induce More Cardiac and Skeletal Myocyte Apoptosis and Necrosis In Vivo Than Others
Abstract
We sought to determine the relative myotoxicity of a sample of cardiotonic (catecholaminergic and PDE Inhibitory) agents currently available for clinical use. Male Wistar rats (292 +/- 24 g) were administered single subcutaneous injections of 20 mmol kg(-1) of each agent. Myocyte apoptosis (caspase-3 and annexin-V) and necrosis (anti-myosin antibody) were detected immunohistochemically on cryosections of the heart and soleus muscle. All of the cardiotonic agents except dopamine produced significant amounts of cardiomyocyte death compared with the vehicle controls, with necrosis (range 2-8%, p < 0.01) approximately one order of magnitude greater in extent than apoptosis (range 0.06-0.5%, p < 0.05). The incidence of necrosis induced by norepinephrine (8%) was approximately twice that of epinephrine and isoproterenol (4 %) and four times that of dobutamine and milrinone (2%). All agents were also toxic to the soleus muscle (range 0.1-8%), but isoproterenol (8%, p < 0.05) and epinephrine (4%, p < 0.05) were the most significant. No cell death was detected in control animals treated with only the vehicle. A majority of cardiotonic agents currently in clinical use are toxic to cardiac and skeletal myocytes. These observations suggest that judicious clinical use of such agents requires careful weighing of potential benefits against the harm via accelerated cumulative loss of myocytes.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
All functions of the sympathetic nervous system are related to allocation of energy-rich fuels and calcium and phosphate to an activated immune system.
“All these functions of the SNS are related to allocation of energy-rich fuels and calcium and phosphate to an activated immune system.”
From Interaction of the endocrine system with inflammation: a function of energy and volume regulation (2014) · cites this paper as [50]
Cites
Apoptosis, oncosis, and necrosis. An overview of cell death.
Majno, G., & Joris, I. (1995) · PubMed · Cited by 3,328 · see citing works
Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
Packer, M., Carver, J. R., Rodeheffer, R. J., Ivanhoe, R. J., DiBianco, R., Zeldis, S. M., Hendrix, G., Bommer, W. J., Elkayam, U., Kukin, M. L., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199111213252103 · Cited by 2,218 · see citing works
Apoptosis in the Failing Human Heart
Olivetti, G., Abbi, R., Quaini, F., Kajstura, J., Cheng, W., Nitahara, J. A., Quaini, E., Di Loreto, C., Beltrami, C. A., Krajewski, S., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704173361603 · Cited by 1,673 · see citing works
Apoptosis in Myocytes in End-Stage Heart Failure
Narula, J., Haider, N., Virmani, R., DiSalvo, T. G., Kolodgie, F. D., Hajjar, R. J., Schmidt, U., Semigran, M. J., Dec, G. W., & Khaw, B.-A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199610173351603 · Cited by 1,430 · see citing works
Adrenergic effects on the biology of the adult mammalian cardiocyte.
Mann, D. L., Kent, R. L., Parsons, B., & Cooper, G. (1992) · Circulation · doi:10.1161/01.cir.85.2.790 · Cited by 865 · see citing works
Anker, S. D., Chua, T. P., Ponikowski, P., Harrington, D., Swan, J. W., Kox, W. J., Poole-Wilson, P. A., & Coats, A. J. S. (1997) · Circulation · doi:10.1161/01.cir.96.2.526 · Cited by 800 · see citing works
Progressive hypertrophy and heart failure in β 1 -adrenergic receptor transgenic mice
Engelhardt, S. H., Hein, L., Wiesmann, F., & Lohse, M. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.12.7059 · Cited by 784 · see citing works
A mechanistic role for cardiac myocyte apoptosis in heart failure
Wencker, D., Chandra, M., Nguyen, K., Miao, W., Garantziotis, S., Factor, S. M., Shirani, J., Armstrong, R. C., & Kitsis, R. N. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17664 · Cited by 765 · see citing works
Communal, C., Singh, K., Pimentel, D. R., & Colucci, W. S. (1998) · Circulation · doi:10.1161/01.cir.98.13.1329 · Cited by 690 · see citing works
Adrenergic and Muscarinic Receptors in the Human Heart
Brodde, O., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673 · see citing works
Heart failure etiology and response tomilrinone in decompensated heart failure
Felker, G. M., Benza, R. L., Chandler, A. B., Leimberger, J. D., Cuffe, M. S., Califf, R. M., Gheorghiade, M., & O’Connor, C. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02968-6 · Cited by 517 · see citing works
Apoptosis and heart failure: A critical review of the literature.
Kang, P., & Izumo, S. (2000) · Circulation Research · doi:10.1161/01.res.86.11.1107 · Cited by 478 · see citing works
Thackray, S. D. R., Easthaugh, J., Freemantle, N., & Cleland, J. G. F. (2002) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00041-7 · Cited by 319 · see citing works
Inotropic therapy for heart failure: An evidence-based approach
Felker, G. M., & O’Connor, C. M. (2001) · American Heart Journal · doi:10.1067/mhj.2001.117606 · Cited by 232 · see citing works
Cardiomyocyte apoptosis and progression of heart failure to transplantation
Saraste, Pulkki, Kallajoki, Heikkilä, Laine, Mattila, Nieminen, Parvinen, & Voipio-Pulkki (1999) · European Journal of Clinical Investigation · doi:10.1046/j.1365-2362.1999.00481.x · Cited by 229 · see citing works
Cardiomyocyte Death Induced by Myocardial Ischemia and Reperfusion
Dumont, E. A. W. J., Hofstra, L., van Heerde, W. L., van den Eijnde, S., Doevendans, P. A., deMuinck, E. D., Daemen, M. A. R. C., Smits, J. F. M., Frederik, P. M., Wellens, H. J. J., et al. (2000) · Circulation · doi:10.1161/01.cir.102.13.1564 · Cited by 177 · see citing works
β-Adrenergic Pathway Induces Apoptosis through Calcineurin Activation in Cardiac Myocytes*
Saito, S., Hiroi, Y., Zou, Y.-Z., Aikawa, R., Toko, H., Shibasaki, F., Yazaki, Y., Nagai, R., & Komuro, I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002844200 · Cited by 169 · see citing works
Xiao, R.-P., Zhu, W., Zheng, M., Chakir, K., Bond, R. A., Lakatta, E. G., & Cheng, H. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.05.007 · Cited by 146 · see citing works
Stevenson, L. W. (2003) · Circulation · doi:10.1161/01.cir.0000078348.44634.ba · Cited by 116 · see citing works
Cardiomyocyte Death and the Ageing and Failing Heart
Goldspink, D. F., Burniston, J. G., & Tan, L. (2003) · Experimental Physiology · doi:10.1113/eph8802549 · Cited by 109 · see citing works
Self-citationGoldspink, D. F., Burniston, J. G., Ellison, G. M., Clark, W. A., & Tan, L. (2004) · Experimental Physiology · doi:10.1113/expphysiol.2004.027482 · Cited by 96 · see citing works
Self-citationβ2-Adrenergic receptor stimulation in vivo induces apoptosis in the rat heart and soleus muscle
Burniston, J. G., Tan, L., & Goldspink, D. F. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00642.2004 · Cited by 80 · see citing works
Self-citationCesario, D. A., Clark, J., & Maisel, A. (1998) · American Heart Journal · doi:10.1016/s0002-8703(98)70352-7 · Cited by 80 · see citing works
Heart failure-related myopathy. Clinical and pathophysiological insights
Opasich, C. (1999) · European Heart Journal · doi:10.1053/euhj.1999.1523 · Cited by 56 · see citing works
Tan, L., Burniston, J. G., Clark, W. A., Ng, Y., & Goldspink, D. F. (2003) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-200304000-00003 · Cited by 43 · see citing works
Self-citationKini, A. A., & Sharma, S. K. (2001) · PubMed · Cited by 42 · see citing works
Levosimendan: a parenteral calcium-sensitising drug with additional vasodilatory properties
Lehtonen, L. (2001) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.10.5.955 · Cited by 41 · see citing works
López‐Candales, A., Carron, C., & Schwartz, J. S. (2004) · Clinical Cardiology · doi:10.1002/clc.4960270107 · Cited by 38 · see citing works
Role of nonglycosidic inotropic agents: indications, ethics, and limitations
Chatterjee, K., & Marco, T. D. (2003) · Medical Clinics of North America · doi:10.1016/s0025-7125(02)00185-2 · Cited by 30 · see citing works
Holubarsch, C. (2008) · Cardiology · doi:10.1159/000177480 · Cited by 30 · see citing works
Yoneyama, M., Sugiyama, A., Satoh, Y., Takahara, A., Nakamura, Y., & Hashimoto, K. (2002) · Circulation Journal · doi:10.1253/circj.66.1150 · Cited by 26 · see citing works
Bryan‐Lluka, L. J., & O’Donnell, S. R. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00167565 · Cited by 26 · see citing works
Greenberg, B., Borghi, C., & Perrone, S. V. (2003) · European Journal of Heart Failure · doi:10.1016/s1388-9842(02)00118-6 · Cited by 21 · see citing works
The case against outpatient parenteral inotropic therapy for advanced heart failure
Rapezzi, C., Bracchetti, G., Branzi, A., & Magnani, B. (2000) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(00)00111-x · Cited by 21 · see citing works
Profile of ligand binding to the porcine beta2-adrenergic receptor.
Liang, W., & Mills, S. E. (2001) · Journal of Animal Science · doi:10.2527/2001.794877x · Cited by 18 · see citing works
Clinical overview of the novel inotropic agent toborinone
MacGowan, G. A. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.5.1109 · Cited by 10 · see citing works
Models of Dilated Cardiomyopathy in Small Animals and Novel Positive Inotropic Therapies
Hoshijima, M. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1302.028 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Sympathetic Overstimulation During Critical Illness: Adverse Effects of Adrenergic Stress
Dünser, M. W., & Hasibeder, W. R. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609340519 · Cited by 485 · see citing works
Use of inotropes and vasopressor agents in critically ill patients
Bangash, M. N., Kong, M., & Pearse, R. M. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01588.x · Cited by 196 · see citing works
Interaction of the endocrine system with inflammation: a function of energy and volume regulation
Straub, R. H. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4484 · Cited by 121 · see citing works
Norepinephrine transporter function and human cardiovascular disease
Schroeder, C., & Jordan, J. (2012) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00492.2012 · Cited by 109 · see citing works
Cardiac contractility modulation therapy in advanced systolic heart failure
Lyon, A. R., Samara, M. A., & Feldman, D. S. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2013.114 · Cited by 92 · see citing works
Ducrocq, N., Kimmoun, A., Furmaniuk, A., Hekalo, Z., Maskali, F., Poussier, S., Marie, P., & Lévy, B. (2012) · Anesthesiology · doi:10.1097/aln.0b013e31824f9669 · Cited by 76 · see citing works
Increasing Mean Arterial Pressure in Cardiogenic Shock Secondary to Myocardial Infarction
Perez, P., Kimmoun, A., Blime, V., & Lévy, B. (2014) · Shock · doi:10.1097/shk.0000000000000099 · Cited by 63 · see citing works
Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker
O'Brien, P. J. (2006) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.6.5.685 · Cited by 55 · see citing works
Schmittinger, C. A., Wurzinger, B., Deutinger, M., Wohlmuth, C., Knotzer, H., Torgersen, C., Dünser, M. W., & Hasibeder, W. R. (2009) · Medical Hypotheses · doi:10.1016/j.mehy.2009.10.012 · Cited by 34 · see citing works
Calcium and zinc dyshomeostasis during isoproterenol-induced acute stressor state
Shahbaz, A. U., Zhao, T., Zhao, W., Johnson, P. L., Ahokas, R. A., Bhattacharya, S. K., Sun, Y., Gerling, I., & Weber, K. T. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00900.2010 · Cited by 33 · see citing works
Clenbuterol and the horse revisited
Kearns, C. F., & McKeever, K. H. (2008) · The Veterinary Journal · doi:10.1016/j.tvjl.2008.08.021 · Cited by 30 · see citing works
Chemical and Biological Properties of Frequent Screening Hits
Che, J., King, F. J., Zhou, B., & Zhou, Y. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300005y · Cited by 24 · see citing works
Burniston, J. G., Tan, L., & Goldspink, D. F. (2006) · Experimental Physiology · doi:10.1113/expphysiol.2006.035014 · Cited by 19 · see citing works
Self-citationHimmerich, H., Ehrlinger, M., Hackenberg, M., Löhr, B., & Nickel, T. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000245560.21907.a4 · Cited by 15 · see citing works
Selcuk, Ö., Ünal, D. N., Dindar, Ç. K., Süslü, İ., & Uslu, B. (2022) · Microchemical Journal · doi:10.1016/j.microc.2022.107720 · Cited by 14 · see citing works
Cardioprotective effect of erythropoietin on sepsis-induced myocardial injury in rats
Qin, Y., Zhang, X.-L., Yu, Y.-Q., Bian, X., & Dong, S. (2013) · World Journal of Emergency Medicine · doi:10.5847/wjem.j.issn.1920-8642.2013.03.011 · Cited by 11 · see citing works
Nakata, T. M., Tanaka, R., Yoshiyuki, R., Fukayama, T., Goya, S., & Fukushima, R. (2015) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000236 · Cited by 10 · see citing works
Manati, W., Vaillant, F., Bost, M., Maffre, V., Belhani, D., Descotes, J., Tabib, A., Bui‐Xuan, B., Hamdan, L., & Timour, Q. (2009) · Human & Experimental Toxicology · doi:10.1177/0960327109106968 · Cited by 8 · see citing works
Toxicogenomic Analysis of Cardiotoxicity in Rats
Hirakawa, B. P., Jessen, B. A., Illanes, O., de Peyster, A., McDermott, T., & Stevens, G. J. (2008) · Genomics Insights · doi:10.4137/gei.s851 · Cited by 7 · see citing works
Inotropic effect of a new probiotic product on myocardial contractility. Comparison with diazoxide
Sobol, C. V., Korotkov, S. M., & Нестеров, В. П. (2014) · BIOPHYSICS · doi:10.1134/s000635091405025x · Cited by 6 · see citing works
Medication use associated with exposure to manganese in two Ohio towns
Bowler, R. M., Adams, S. W., Wright, C. W., Kim, Y., Booty, A., Colledge, M., Gocheva, V. V., & Lobdell, D. T. (2016) · International Journal of Environmental Health Research · doi:10.1080/09603123.2016.1194381 · Cited by 6 · see citing works
Tan, L., Hothi, S. S., & Tan, D. K. H. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.01.090 · Cited by 4 · see citing works
Self-citationRole of selenium in heart lesions produced by neuroleptics in the rabbit
Vaillant, F., Turrel, F., Bost, M., Bricca, G., Descotes, J., Bui‐Xuan, B., Tabib, A., Manati, W., & Timour, Q. (2007) · Journal of Applied Toxicology · doi:10.1002/jat.1279 · Cited by 4 · see citing works
Peng, D., Feng, F., Yin, H., Zhao, J., Cao, S., Zhang, L., & Liu, J. (2026) · Biological Trace Element Research · doi:10.1007/s12011-026-05143-0 · Cited by 2 · see citing works
Zhu, H., Ma, P., Qian, Y., Xia, J., Gong, F., Chen, L., & Xu, L. (2022) · Biosensors · doi:10.3390/bios12100777 · Cited by 2 · see citing works
Effects of Normobaric Hypoxia and Adrenergic Blockade over 72 h on Cardiac Function in Rats
Neubert, E., Raßler, B., Hoschke, A., Raffort, C., & Salameh, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411417 · Cited by 4 · see citing works
Bradley, A., Fant, P., Guionaud, S., Boyle, M., Alison, R., & Hargreaves, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-391448-4.00030-7 · Cited by 2 · see citing works
Hartjes, A., Wurzinger, B., Neubauer, G., Wieczorek-Waltenberger, S., Dünser, M. W., & Hasibeder, W. R. (2013) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.7872 · Cited by 1 · see citing works
Agentes infecciosos e inflamação em miocárdio de pacientes com miocardiopatia dilatada
Mangini, S. (2013) · doi:10.11606/t.5.2013.tde-14082013-162502 · Cited by 1 · see citing works
Ginwalla, M. B., & Bianco, C. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809657-4.99662-5 · Cited by 1 · see citing works
Calcium Overloading-Induced Oxidative Stress-Mediated Cellular and Subcellular Remodeling
Cheema, Y., Shahbaz, A. U., Bhattacharya, S. K., Ahokas, R. A., Sun, Y., Gerling, I., & Weber, K. T. (2011) · Springer eBooks · doi:10.1007/978-1-4419-7130-2_1
Efeitos do metoprolol em modelo experimental de choque
Paulo, S. (2014)
OBSOLETE: Inotropes in Heart Failure
Ginwalla, M. B. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.99662-4
Frommeyer, T. C., Butman, J., Pervaiz, S., Brittain, G. V., Patel, P. N., & Baliga, R. R. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-15734-9.00065-0
- Authors
- Burniston, J. G., Ellison, G. M., Clark, W. A., Goldspink, D. F., & Tan, L.-B.
- Affiliations
- Liverpool John Moores University (GB)
- University of Leeds (GB)
- Corresponding author
- Burniston, Jatin G.
- Venue
- Cardiovascular Toxicology
- Published
- 2005
- Volume
- 5
- Issue
- 4
- Pages
- 355-364
- ISSN
- 1530-7905 (ISSN-L)
- OpenAlex
- W2023582801
- Cited by
- 35
- References
- 37
- Citations by year
- 2026: 2 · 2023: 1 · 2022: 2 · 2017: 3 · 2016: 1 · 2015: 1 · 2014: 5 · 2013: 4 · 2012: 4
- FWCI
- 0.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cardiovascular Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- Fonds National de la Recherche Luxembourg
- Liverpool John Moores University
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
- Keywords
- cardiotonic agents, myotoxicity, cardiomyocyte apoptosis, myocardial necrosis, catecholamines, norepinephrine, epinephrine, isoproterenol, dobutamine, milrinone, dopamine, phosphodiesterase inhibitors, caspase-3, annexin V, soleus muscle
- MeSH terms
- Animals, Cardiotonic Agents, Disease Models, Animal, Dose-Response Relationship, Drug, Heart, Image Processing, Computer-Assisted, Immunoenzyme Techniques, Injections, Subcutaneous, Isoproterenol, Male, Myocardium, Necrosis, Apoptosis, Muscle, Skeletal, Muscle Fibers, Skeletal, Myocytes, Cardiac, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review